You’ve got to eat, so why not log in and learn as you munch? Our speakers Kemal Oflus and Brian Washington (JMP) will walk us through modern Design of Experiment techniques that can explore multiple variables with a minimal number of tests. Brian will be demonstrating the JMP platform to show how DOE techniques can make work formulation faster, and more efficient.
11:30am – 12:30am Eastern, Friday November 5th via Zoom.
Please register for tomorrow’s Lunch ‘n Learn on statistical experimental design, presented by: JMP a SAS Company. This Zoom meeting is part of the Georgia Local Section of the American Chemical Society event programming.
Bought to life with video footage, case studies, a pop-up glossary and original illustrations, “Prototype to Profit” journeys the path of inventors wishing to commercialize their own product, including budgeting, funding, marketing, deal making with collaborators, creativity-on-demand, intellectual property basics, and IP strategy. The multimedia book boils down years of experience including new product development, problem solving, intellectual property (IP) strategy, and entrepreneur ship. Prototype to Profit was completed during the SARS-CoV-2 pandemic, and includes examples of company pivots and adaptations that helped enterprises survive the rough years of Covid-19 lockdown. Published by ACS, the book is included in the inaugural “InFocus” series, brought to life through videos, animations, and “Day in the Life” case studies, delivered in an e-reader that enables learning when it suits you.
Lyco Works has been working with Slingshot Product Development Group in Lawrenceville GA recently. Here’s how we’ve been helping their clients develop an IP strategy to help patent protect the new products that Slingshot creates for them…
How similar are your chemical structures to those mentioned in your competitor’s patents?
Who’s running clinical trials on compounds similar to you own? What stage are they at?
Which visually similar chemical compounds are discussed in the patent literature? Which are not?
With an expanded license to powerful software, we are able to answer these questions for you. We synthesize these data into a customized dashboard, and add business impact for your specific concerns and needs. Read the rest of this entry »
Dr. Cynthia Boxrud formulated a pharmaceutical active into a cream and used it in her plastic surgery practice. She found that it significantly reduced the dark discoloration and swelling under the eyes.
Case #1: Before
Case #2: Before
Four products were developed, and sold on the QVC Shopping Channel. The product was successful in the marketplace, however, Dr. Boxrud made the decision to return to her surgical practice full time, and eventually decided to sell the technology.
In one way or another, very few of us are left untouched by this disease. As many of you know, it’s been almost a yearsince I lost my Dad to cancer (along with several friends, I might add) so I was interested to read in Chemical & Engineering News (C&EN Vol. 95 No. 11 July 3rd, 2017) that a new drug has been approved that treats cancers in any tissue –provided that the patient has a specific genetic profile. The FDA approval of Keytruda® (Merck & Co.) illuminates a paradigm shift in the approach to cancer research.Read the rest of this entry »